Pablo Llerena

Also affiliated with Thomas Jefferson University Hospital, Universidad de Las Américas, Sidney Kimmel Cancer Center, Instituto Nacional de Biodiversidad, SOLCA Núcleo de Quito, Universidad San Francisco de Quito

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Extracellular Matrix–MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC”.

Extracellular Matrix–MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1098

N/A

0.241DataRank · unranked

4 citations

Hani Samarah, Kathryn L. Nunes, Zhao Lin, Kelly Bridgham, Sruti Tekumalla +28 more

Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0037

N/A

0DataRank · unranked

10 citations

Kathryn L. Nunes, Pablo Llerena, Anastasia Nikitina, Anastasia Sobol, E. Reilly Scott +30 more